Lipitor

Rediff.com » News » Lipitor

News for Lipitor

Business

Lipitor settlement gets thumbs-down

Shares of Ranbaxy Laboratories on Thursday fell 7.67 per cent on the Bombay Stock Exchange to Rs 552.25 at close, after top investment banks like JP Morgan and CLSA said the out-of-court settlement......

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Pfizer Inc and Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug......

Ranbaxy's plan for Lipitor fuels speculation

With hardly four weeks for patent expiry of the world's largest revenue earning drug, Lipitor, in the US, speculation is rife as to how Ranbaxy will exploit this.The generic products company had......

Ranbaxy loses Lipitor patent case in Denmark

Pfizer has won a patent challenge in Denmark by India's largest drug-maker Ranbaxy Laboratories on atorvastatin, the active ingredient of the world's largest selling cholesterol drug, Lipitor,......

Ranbaxy launches Lipitor's generic version in US

Drug major Ranbaxy Laboratories has launched its generic version of blockbuster cholesterol-lowering drug Lipitor in the US market.The launch came after final approval from the US health regulator......

Lipitor

News for Lipitor

Lipitor settlement gets thumbs-down

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Ranbaxy's plan for Lipitor fuels speculation

Ranbaxy loses Lipitor patent case in Denmark

Ranbaxy launches Lipitor's generic version in US

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS